SBI Healthcare Opportunities Fund
- NAV as on 25 Sep 2026
- ₹521.68-0.27%1 day
- Return since launch
- 16.8%
- 52-week range
- ₹402.11 — ₹527.39
- AUM
- ₹5,796 Cr
SBI Healthcare Opportunities Fund is a Sectoral-Pharma equity fund from SBI Mutual Fund with ₹5,796 Cr under management, launched in 1999. Over three years it has returned 19.9% a year, against 21.1% for its category. The expense ratio is 2.00% and the SEBI riskometer reading is Very High.
Performance
SBI Healthcare Opportunities Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +24.3% against +19.4% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 32.5% | +11.8 pts | 20.7% | 26.0% |
| 2Y | 19.3% | +2.5 pts | 16.8% | 15.1% |
| 3Y | 19.9% | −1.2 pts | 21.1% | 15.8% |
| 5Y | 22.3% | +8.0 pts | 14.3% | 18.1% |
| 7Y | 22.0% | +2.8 pts | 19.2% | 18.1% |
| 10Y | 19.6% | +5.9 pts | 13.7% | 16.9% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 0.3% | +0.2 pts | 0.2% | 0.2% |
| 3M | 6.5% | +0.2 pts | 6.3% | 5.9% |
| 6M | 23.8% | +1.8 pts | 22.0% | 20.9% |
| 1Y | 24.3% | +3.6 pts | 20.7% | 19.5% |
| 2Y | 11.5% | +3.3 pts | 8.2% | 6.8% |
| 3Y | 23.7% | +2.6 pts | 21.1% | 20.6% |
| 5Y | 17.6% | +3.3 pts | 14.3% | 13.3% |
| 7Y | 24.7% | +2.3 pts | 22.4% | 21.1% |
| 10Y | 13.4% | −0.2 pts | 13.7% | 12.2% |
Since launch (4 Jun 1999): 16.8%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -3.5% | −1.5 pts | -2.0% |
| 2024 | 42.2% | +1.4 pts | 40.9% |
| 2023 | 38.2% | +2.0 pts | 36.2% |
| 2022 | -6.0% | +2.3 pts | -8.3% |
| 2021 | 20.1% | −1.5 pts | 21.7% |
| 2020 | 65.8% | −3.0 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
1.99%
Expense ratio as on 22 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.57%
- Brokerage
- 0.04%
- Transaction charges
- 0.00%
- Statutory levies
- 0.38%
- Exit load
- Exit load of 0.50% if redeemed within 15 days
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | 2.37 | 0.34 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.86 | 0.95 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 1.17 | 1.02 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.92 | 1.56 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 14.37 | 16.00 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 4 category peers | |||
Portfolio
SBI Healthcare Opportunities Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity96.8%
- Debt0.1%
- Other3.2%
Market cap split
- Large36.0%
- Mid28.9%
- Small35.2%
- P/E
- 58.38
- P/B
- 6.61
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 12.33% | ₹715 Cr | +11.03% | +10.65% | +10.86% |
| Divi's Laboratories Ltd. | Healthcare | 8.17% | ₹473 Cr | +6.57% | +7.55% | +6.81% |
| Acutaas Chemicals Ltd. | Healthcare | 4.91% | ₹284 Cr | +6.17% | +4.77% | +3.19% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 4.91% | ₹285 Cr | +5.37% | +5.76% | — |
| Torrent Pharmaceuticals Ltd. | Healthcare | 4.72% | ₹274 Cr | +3.48% | +4.25% | +3.59% |
| Cipla Ltd. | Healthcare | 4.67% | ₹271 Cr | +1.84% | — | +4.81% |
| Max Healthcare Institute Ltd. | Healthcare | 4.31% | ₹250 Cr | +4.76% | +4.82% | +6.12% |
| Laurus Labs Ltd. | Healthcare | 3.96% | ₹230 Cr | +3.58% | +3.48% | +3.03% |
| Aurobindo Pharma Ltd. | Healthcare | 3.90% | ₹226 Cr | +3.90% | — | +1.82% |
| Aster DM Quality Care Ltd. | Healthcare | 3.52% | ₹204 Cr | +3.83% | +3.85% | +3.03% |
| Others | Others | 3.16% | ₹184 Cr | -0.06% | -0.52% | -1.16% |
| Gland Pharma Ltd. | Healthcare | 2.99% | ₹173 Cr | +2.96% | +2.68% | +3.31% |
| Anthem Biosciences Ltd. | Healthcare | 2.90% | ₹168 Cr | +3.00% | +2.68% | +2.48% |
| Sudeep Pharma Ltd. | Healthcare | 2.84% | ₹165 Cr | +2.21% | +2.13% | — |
| Fortis Healthcare Ltd. | Healthcare | 2.82% | ₹163 Cr | +3.05% | +3.24% | +3.45% |
| Biocon Ltd. | Healthcare | 2.67% | ₹155 Cr | +3.52% | +3.59% | +2.81% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.55% | ₹148 Cr | +2.62% | +2.79% | +2.90% |
| Sai Life Sciences Ltd. | Healthcare | 2.52% | ₹146 Cr | +2.54% | +1.96% | — |
| Concord Biotech Ltd. | Healthcare | 2.40% | ₹139 Cr | +1.66% | +2.16% | +3.06% |
| Aether Industries Ltd. | Chemicals | 2.33% | ₹135 Cr | +2.65% | +3.29% | +2.60% |
| Poly Medicure Ltd. | Healthcare | 1.94% | ₹113 Cr | +1.89% | +1.97% | +2.98% |
| Global Health Ltd. | Healthcare | 1.91% | ₹111 Cr | +1.46% | — | — |
| Ajanta Pharma Ltd. | Healthcare | 1.86% | ₹108 Cr | +1.92% | +1.84% | — |
| Cohance Lifesciences Ltd. | Healthcare | 1.73% | ₹100 Cr | +1.70% | +0.91% | +1.78% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 1.73% | ₹101 Cr | +1.99% | +2.92% | +3.20% |
| Mankind Pharma Ltd. | Healthcare | 1.67% | ₹96.77 Cr | +2.91% | +2.98% | +3.49% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.47% | ₹85.12 Cr | +0.84% | — | — |
| Healthcare Global Enterprises Ltd. | Healthcare | 1.27% | ₹73.33 Cr | — | — | — |
| Syngene International Ltd. | Healthcare | 1.24% | ₹72.14 Cr | — | — | — |
| Nephrocare Health Services Ltd. | Healthcare | 1.18% | ₹68.30 Cr | +1.05% | +1.17% | — |
| Rainbow Children's Medicare Ltd. | Healthcare | 0.73% | ₹42.44 Cr | +0.91% | — | +2.12% |
| Abbott India Ltd. | Healthcare | 0.35% | ₹20.07 Cr | +1.47% | +1.95% | +2.86% |
| Gufic Biosciences Ltd. | Healthcare | 0.29% | ₹16.65 Cr | +0.37% | +0.69% | +0.93% |
| Reserve Bank of India | Financial | 0.05% | ₹2.97 Cr | +0.06% | +0.07% | +0.07% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Lupin Ltd. | 1.79% | 0.00% | -1.79% |
| Divi's Laboratories Ltd. | 7.46% | 8.17% | +0.71% |
| Abbott India Ltd. | 1.03% | 0.35% | -0.68% |
| Sudeep Pharma Ltd. | 2.22% | 2.84% | +0.62% |
| Healthcare Global Enterprises Ltd. | 0.73% | 1.27% | +0.54% |
| Concord Biotech Ltd. | 1.89% | 2.40% | +0.51% |
| Dr. Lal Pathlabs Ltd. | 1.06% | 1.47% | +0.41% |
| Cipla Ltd. | 5.07% | 4.67% | -0.40% |
| Sun Pharmaceutical Industries Ltd. | 12.72% | 12.33% | -0.39% |
| Jupiter Life Line Hospitals Ltd. | 2.88% | 2.55% | -0.33% |
| Biocon Ltd. | 2.96% | 2.67% | -0.29% |
| Syngene International Ltd. | 0.96% | 1.24% | +0.28% |
| Max Healthcare Institute Ltd. | 4.58% | 4.31% | -0.27% |
| Acutaas Chemicals Ltd. | 5.17% | 4.91% | -0.26% |
| Krishna Institute of Medical Sciences Ltd | 1.98% | 1.73% | -0.25% |
| Global Health Ltd. | 1.67% | 1.91% | +0.24% |
| Gland Pharma Ltd. | 2.78% | 2.99% | +0.21% |
| Fortis Healthcare Ltd. | 2.63% | 2.82% | +0.19% |
| Mankind Pharma Ltd. | 1.83% | 1.67% | -0.16% |
| Aster DM Quality Care Ltd. | 3.65% | 3.52% | -0.13% |
| Rainbow Children's Medicare Ltd. | 0.85% | 0.73% | -0.12% |
| Anthem Biosciences Ltd. | 2.82% | 2.90% | +0.08% |
| Laurus Labs Ltd. | 4.04% | 3.96% | -0.08% |
| Poly Medicure Ltd. | 2.02% | 1.94% | -0.08% |
| Sai Life Sciences Ltd. | 2.44% | 2.52% | +0.08% |
| Apollo Hospitals Enterprise Ltd. | 4.98% | 4.91% | -0.07% |
| Gufic Biosciences Ltd. | 0.36% | 0.29% | -0.07% |
| Ajanta Pharma Ltd. | 1.93% | 1.86% | -0.07% |
| Aether Industries Ltd. | 2.28% | 2.33% | +0.05% |
| Aurobindo Pharma Ltd. | 3.86% | 3.90% | +0.04% |
| Others | -0.92% | -0.95% | -0.03% |
| Torrent Pharmaceuticals Ltd. | 4.74% | 4.72% | -0.02% |
| Nephrocare Health Services Ltd. | 1.20% | 1.18% | -0.02% |
| Cohance Lifesciences Ltd. | 1.73% | 1.73% | 0.00% |
| Reserve Bank of India | 0.05% | 0.05% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,024 Cr | 2.25% | 25.4% | 17.2% | 19.6% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.0% | 14.2% | 19.5% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 29.6% | 18.5% | 19.8% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 29.8% | 19.1% | 21.1% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.3% | 16.9% | 17.9% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund managers
- Tanmaya DesaiMr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months23.82% absolute | ₹60,000 | ₹74,292 | 23.82% | |
| 1 year24.31% annualised | ₹1,20,000 | ₹1,37,037 | 14.20% | |
| 3 years23.72% annualised | ₹3,60,000 | ₹5,27,848 | 46.62% | |
| 5 years17.62% annualised | ₹6,00,000 | ₹9,66,013 | 61.00% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.